243 related articles for article (PubMed ID: 31127093)
1. MiR-30 family prevents uPAR-ITGB3 signaling activation through calcineurin-NFATC pathway to protect podocytes.
Lang Y; Zhao Y; Zheng C; Lu Y; Wu J; Zhu X; Zhang M; Yang F; Xu X; Shi S; Liu Z
Cell Death Dis; 2019 May; 10(6):401. PubMed ID: 31127093
[TBL] [Abstract][Full Text] [Related]
2. The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury.
Zhang B; Shi W; Ma J; Sloan A; Faul C; Wei C; Reiser J; Yang Y; Liu S; Wang W
J Mol Med (Berl); 2012 Dec; 90(12):1407-20. PubMed ID: 23015147
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-30 family members regulate calcium/calcineurin signaling in podocytes.
Wu J; Zheng C; Wang X; Yun S; Zhao Y; Liu L; Lu Y; Ye Y; Zhu X; Zhang C; Shi S; Liu Z
J Clin Invest; 2015 Nov; 125(11):4091-106. PubMed ID: 26436650
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II induces calcium/calcineurin signaling and podocyte injury by downregulating microRNA-30 family members.
Zhao Y; Wu J; Zhang M; Zhou M; Xu F; Zhu X; Zhou X; Lang Y; Yang F; Yun S; Shi S; Liu Z
J Mol Med (Berl); 2017 Aug; 95(8):887-898. PubMed ID: 28540409
[TBL] [Abstract][Full Text] [Related]
5. Amiloride off-target effect inhibits podocyte urokinase receptor expression and reduces proteinuria.
Zhang B; Xie S; Shi W; Yang Y
Nephrol Dial Transplant; 2012 May; 27(5):1746-55. PubMed ID: 22076430
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids.
Wu J; Zheng C; Fan Y; Zeng C; Chen Z; Qin W; Zhang C; Zhang W; Wang X; Zhu X; Zhang M; Zen K; Liu Z
J Am Soc Nephrol; 2014 Jan; 25(1):92-104. PubMed ID: 24029422
[TBL] [Abstract][Full Text] [Related]
7. RANK Deficiency Ameliorates Podocyte Injury by Suppressing Calcium/Calcineurin/ NFATc1 Signaling.
Liang S; Zhang H; Du Y; Dou C; Liu S; Zhang L; Chen Y; Li R; Ma J; Li Z; Lin T; Zhao X; Zhang Q; Wang W; Ye Z; Liang X; Shi W; Zhang B
Kidney Blood Press Res; 2018; 43(4):1149-1159. PubMed ID: 30036881
[TBL] [Abstract][Full Text] [Related]
8. 1,25-dihydroxyvitamin D(3) inhibits podocyte uPAR expression and reduces proteinuria.
Ma J; Zhang B; Liu S; Xie S; Yang Y; Ma J; Deng Y; Wang W; Xu L; Li R; Zhang L; Yu C; Shi W
PLoS One; 2013; 8(5):e64912. PubMed ID: 23741418
[TBL] [Abstract][Full Text] [Related]
9. NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice.
Zhang L; Li R; Shi W; Liang X; Liu S; Ye Z; Yu C; Chen Y; Zhang B; Wang W; Lai Y; Ma J; Li Z; Tan X
Br J Pharmacol; 2013 Sep; 170(2):426-39. PubMed ID: 23826864
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin promotes podocyte migration through the up-regulation of urokinase receptor.
Wu MJ; Chang CH; Shu KH; Ho HC; Li JR; Fu YC
Transplant Proc; 2014 May; 46(4):1226-8. PubMed ID: 24815166
[TBL] [Abstract][Full Text] [Related]
11. Podocyte injury-driven intracapillary plasminogen activator inhibitor type 1 accelerates podocyte loss via uPAR-mediated β1-integrin endocytosis.
Kobayashi N; Ueno T; Ohashi K; Yamashita H; Takahashi Y; Sakamoto K; Manabe S; Hara S; Takashima Y; Dan T; Pastan I; Miyata T; Kurihara H; Matsusaka T; Reiser J; Nagata M
Am J Physiol Renal Physiol; 2015 Mar; 308(6):F614-26. PubMed ID: 25587125
[TBL] [Abstract][Full Text] [Related]
12. Calcineurin inhibitors ameliorate PAN-induced podocyte injury through the NFAT-Angptl4 pathway.
Shen X; Zhang Y; Lin C; Weng C; Wang Y; Feng S; Wang C; Shao X; Lin W; Li B; Wang H; Chen J; Jiang H
J Pathol; 2020 Nov; 252(3):227-238. PubMed ID: 32686149
[TBL] [Abstract][Full Text] [Related]
13. The Krüppel-like factor 15-NFATc1 axis ameliorates podocyte injury: a novel rationale for using glucocorticoids in proteinuria diseases.
Dou C; Zhang H; Ke G; Zhang L; Lian Z; Chen X; Zhao X; Chen Y; Li R; Ma J; Li Z; Lin T; Wang W; Ye ZM; Liang X; Shi W; Zhang B; Liu S
Clin Sci (Lond); 2020 Jun; 134(12):1305-1318. PubMed ID: 32478397
[TBL] [Abstract][Full Text] [Related]
14. Calcineurin (CN) activation promotes apoptosis of glomerular podocytes both in vitro and in vivo.
Wang L; Chang JH; Paik SY; Tang Y; Eisner W; Spurney RF
Mol Endocrinol; 2011 Aug; 25(8):1376-86. PubMed ID: 21622531
[TBL] [Abstract][Full Text] [Related]
15. NFAT2 mediates high glucose-induced glomerular podocyte apoptosis through increased Bax expression.
Li R; Zhang L; Shi W; Zhang B; Liang X; Liu S; Wang W
Exp Cell Res; 2013 Apr; 319(7):992-1000. PubMed ID: 23340267
[TBL] [Abstract][Full Text] [Related]
16. Gq-dependent signaling upregulates COX2 in glomerular podocytes.
Wang L; Flannery PJ; Rosenberg PB; Fields TA; Spurney RF
J Am Soc Nephrol; 2008 Nov; 19(11):2108-18. PubMed ID: 18667730
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.
Nijenhuis T; Sloan AJ; Hoenderop JG; Flesche J; van Goor H; Kistler AD; Bakker M; Bindels RJ; de Boer RA; Möller CC; Hamming I; Navis G; Wetzels JF; Berden JH; Reiser J; Faul C; van der Vlag J
Am J Pathol; 2011 Oct; 179(4):1719-32. PubMed ID: 21839714
[TBL] [Abstract][Full Text] [Related]
18. Amiloride, a urokinase-type plasminogen activator receptor (uTPA) inhibitor, reduces proteinurea in podocytes.
Xu LB; Chi N; Shi W
Genet Mol Res; 2015 Aug; 14(3):9518-29. PubMed ID: 26345885
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase 4 mediates high glucose-induced podocyte apoptosis via upregulation of calcineurin.
Shi W; Huang Y; Zhao X; Xie Z; Dong W; Li R; Chen Y; Li Z; Wang W; Ye Z; Liu S; Zhang L; Liang X
Biochem Biophys Res Commun; 2020 Dec; 533(4):1061-1068. PubMed ID: 33019979
[TBL] [Abstract][Full Text] [Related]
20. MiR-30a Inhibits the Epithelial--Mesenchymal Transition of Podocytes through Downregulation of NFATc3.
Peng R; Zhou L; Zhou Y; Zhao Y; Li Q; Ni D; Hu Y; Long Y; Liu J; Lyu Z; Mao Z; Yuan Y; Huang L; Zhao H; Li G; Zhou Q
Int J Mol Sci; 2015 Oct; 16(10):24032-47. PubMed ID: 26473838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
